Perspective Therapeutics, Inc. (CATX)
USD 1.92
(-1.03%)
USD 1.92
(-1.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -15.18 Million USD | -105.41% |
| 2021 | -7.39 Million USD | -115.04% |
| 2020 | -3.43 Million USD | 1.12% |
| 2019 | -3.47 Million USD | 34.14% |
| 2018 | -5.27 Million USD | 21.56% |
| 2017 | -6.72 Million USD | -6.69% |
| 2016 | -6.3 Million USD | -24.1% |
| 2015 | -5.08 Million USD | -17.2% |
| 2014 | -4.33 Million USD | 5.49% |
| 2013 | -4.58 Million USD | -12.81% |
| 2012 | -4.06 Million USD | -13.04% |
| 2011 | -3.59 Million USD | -21.43% |
| 2010 | -2.96 Million USD | 26.09% |
| 2009 | -4 Million USD | 38.04% |
| 2008 | -6.47 Million USD | 26.49% |
| 2007 | -8.8 Million USD | 9.25% |
| 2006 | -9.69 Million USD | -34.81% |
| 2005 | -7.19 Million USD | 0.0% |
| 2003 | -9095.00 USD | 52.19% |
| 2002 | -19.02 Thousand USD | -150.82% |
| 2001 | -7584.00 USD | 51.29% |
| 2000 | -15.56 Thousand USD | -10.04% |
| 1999 | -14.14 Thousand USD | 8.89% |
| 1998 | -15.53 Thousand USD | 93.03% |
| 1997 | -222.82 Thousand USD | 14.53% |
| 1996 | -260.71 Thousand USD | 87.64% |
| 1995 | -2.1 Million USD | -154.81% |
| 1994 | -827.94 Thousand USD | 29.12% |
| 1993 | -1.16 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -10.53 Million USD | 7.39% |
| 2022 Q3 | -11.2 Million USD | -249.83% |
| 2022 Q1 | -4.2 Million USD | -99.81% |
| 2022 Q2 | -3.2 Million USD | 23.88% |
| 2022 FY | -15.18 Million USD | -105.41% |
| 2022 Q4 | -11.37 Million USD | -1.51% |
| 2021 Q3 | -1.2 Million USD | 26.18% |
| 2021 Q1 | -2.27 Million USD | -108.05% |
| 2021 FY | -7.39 Million USD | -115.04% |
| 2021 Q4 | -2.1 Million USD | -74.48% |
| 2021 Q2 | -1.63 Million USD | 28.1% |
| 2020 Q3 | -766 Thousand USD | 12.26% |
| 2020 Q2 | -873 Thousand USD | -22.27% |
| 2020 Q1 | -714 Thousand USD | 39.95% |
| 2020 FY | -3.43 Million USD | 1.12% |
| 2020 Q4 | -1.09 Million USD | -42.69% |
| 2019 Q3 | -548 Thousand USD | 39.31% |
| 2019 FY | -3.47 Million USD | 34.14% |
| 2019 Q1 | -836 Thousand USD | 26.92% |
| 2019 Q2 | -903 Thousand USD | -8.01% |
| 2019 Q4 | -1.18 Million USD | -116.97% |
| 2018 Q1 | -1.51 Million USD | 35.95% |
| 2018 Q2 | -1.42 Million USD | 5.86% |
| 2018 Q3 | -1.16 Million USD | 18.61% |
| 2018 Q4 | -1.14 Million USD | 1.63% |
| 2018 FY | -5.27 Million USD | 21.56% |
| 2017 Q3 | -1.33 Million USD | 8.79% |
| 2017 FY | -6.72 Million USD | -6.69% |
| 2017 Q2 | -1.46 Million USD | 5.41% |
| 2017 Q1 | -1.55 Million USD | 16.69% |
| 2017 Q4 | -2.37 Million USD | -77.0% |
| 2016 Q1 | -1.57 Million USD | -25.61% |
| 2016 FY | -6.3 Million USD | -24.1% |
| 2016 Q4 | -1.86 Million USD | -34.13% |
| 2016 Q3 | -1.38 Million USD | 6.09% |
| 2016 Q2 | -1.47 Million USD | 6.1% |
| 2015 FY | -5.08 Million USD | -17.2% |
| 2015 Q4 | -1.25 Million USD | 5.51% |
| 2015 Q3 | -1.32 Million USD | 5.92% |
| 2015 Q2 | -1.41 Million USD | -29.33% |
| 2015 Q1 | -1.09 Million USD | 1.19% |
| 2014 Q2 | -1.02 Million USD | 12.13% |
| 2014 Q1 | -1.16 Million USD | 12.06% |
| 2014 Q4 | -1.1 Million USD | -5.02% |
| 2014 FY | -4.33 Million USD | 5.49% |
| 2014 Q3 | -1.05 Million USD | -3.01% |
| 2013 Q2 | -1.04 Million USD | 15.4% |
| 2013 FY | -4.58 Million USD | -12.81% |
| 2013 Q1 | -1.23 Million USD | -20.93% |
| 2013 Q4 | -1.32 Million USD | -33.5% |
| 2013 Q3 | -988.99 Thousand USD | 5.3% |
| 2012 Q1 | -1.12 Million USD | -19.36% |
| 2012 FY | -4.06 Million USD | -13.04% |
| 2012 Q3 | -824.12 Thousand USD | 25.04% |
| 2012 Q2 | -1.09 Million USD | 2.08% |
| 2012 Q4 | -1.02 Million USD | -23.87% |
| 2011 FY | -3.59 Million USD | -21.43% |
| 2011 Q3 | -762.85 Thousand USD | 3.69% |
| 2011 Q4 | -940.65 Thousand USD | -23.31% |
| 2011 Q1 | -1.1 Million USD | -43.83% |
| 2011 Q2 | -792.05 Thousand USD | 28.15% |
| 2010 Q1 | -868.48 Thousand USD | 19.46% |
| 2010 FY | -2.96 Million USD | 26.09% |
| 2010 Q2 | -784.51 Thousand USD | 9.67% |
| 2010 Q3 | -693.43 Thousand USD | 11.61% |
| 2010 Q4 | -766.38 Thousand USD | -10.52% |
| 2009 FY | -4 Million USD | 38.04% |
| 2009 Q1 | -895.21 Thousand USD | 28.18% |
| 2009 Q3 | -1.09 Million USD | -15.4% |
| 2009 Q4 | -1.07 Million USD | 1.1% |
| 2009 Q2 | -944.91 Thousand USD | -5.55% |
| 2008 Q2 | -2.08 Million USD | -25.61% |
| 2008 FY | -6.47 Million USD | 26.49% |
| 2008 Q1 | -1.65 Million USD | -18.28% |
| 2008 Q4 | -1.24 Million USD | 15.93% |
| 2008 Q3 | -1.48 Million USD | 28.82% |
| 2007 Q2 | -2.94 Million USD | -24.2% |
| 2007 Q1 | -2.36 Million USD | 16.86% |
| 2007 Q4 | -1.4 Million USD | 32.97% |
| 2007 FY | -8.8 Million USD | 9.25% |
| 2007 Q3 | -2.09 Million USD | 28.88% |
| 2006 Q4 | -2.84 Million USD | -39.89% |
| 2006 Q2 | -1.9 Million USD | 34.77% |
| 2006 Q1 | -2.91 Million USD | -22.52% |
| 2006 FY | -9.69 Million USD | -34.81% |
| 2006 Q3 | -2.03 Million USD | -7.1% |
| 2005 Q3 | -1.46 Million USD | 5.19% |
| 2005 Q2 | -1.54 Million USD | 14.81% |
| 2005 Q4 | -2.37 Million USD | -62.61% |
| 2005 FY | -7.19 Million USD | 0.0% |
| 2005 Q1 | -1.81 Million USD | 0.0% |
| 2004 Q2 | -3574.00 USD | 14.27% |
| 2004 Q3 | 302.04 Thousand USD | 8551.04% |
| 2004 Q1 | -4169.00 USD | -155.79% |
| 2003 Q2 | -2934.00 USD | 57.91% |
| 2003 FY | -9095.00 USD | 52.19% |
| 2003 Q3 | -1593.00 USD | 45.71% |
| 2003 Q1 | -6971.00 USD | -292.95% |
| 2003 Q4 | 7472.00 USD | 569.05% |
| 2002 Q3 | -2708.00 USD | 64.23% |
| 2002 FY | -19.02 Thousand USD | -150.82% |
| 2002 Q1 | 271.00 USD | 118.3% |
| 2002 Q2 | -7570.00 USD | -2893.36% |
| 2002 Q4 | -1774.00 USD | 34.49% |
| 2001 Q2 | -1495.00 USD | 11.64% |
| 2001 Q3 | -4879.00 USD | -226.35% |
| 2001 Q4 | -1481.00 USD | 69.65% |
| 2001 Q1 | -1692.00 USD | 84.41% |
| 2001 FY | -7584.00 USD | 51.29% |
| 2000 Q4 | -10.85 Thousand USD | -1012.82% |
| 2000 Q2 | -2054.00 USD | 85.41% |
| 2000 Q1 | -14.07 Thousand USD | -58558.33% |
| 2000 FY | -15.56 Thousand USD | -10.04% |
| 2000 Q3 | -975.00 USD | 52.53% |
| 1999 Q3 | -25.00 USD | -4.17% |
| 1999 FY | -14.14 Thousand USD | 8.89% |
| 1999 Q4 | -24.00 USD | 4.0% |
| 1999 Q1 | -12.57 Thousand USD | -1622.33% |
| 1999 Q2 | -24.00 USD | 99.81% |
| 1998 Q2 | -2690.00 USD | 0.0% |
| 1998 Q3 | 463.00 USD | 117.21% |
| 1998 Q4 | -730.00 USD | -257.67% |
| 1998 FY | -15.53 Thousand USD | 93.03% |
| 1997 FY | -222.82 Thousand USD | 14.53% |
| 1996 FY | -260.71 Thousand USD | 87.64% |
| 1995 FY | -2.1 Million USD | -154.81% |
| 1994 FY | -827.94 Thousand USD | 29.12% |
| 1993 FY | -1.16 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Electromed, Inc. | 6.58 Million USD | 330.694% |
| Senseonics Holdings, Inc. | -75.6 Million USD | 79.919% |
| Catheter Precision, Inc. | -78.11 Million USD | 80.566% |
| Xtant Medical Holdings, Inc. | -10.15 Million USD | -49.459% |